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Abstract
Background: The diagnosis of inflammatory bowel disease
(IBD) in children and adolescents is based on the integration
of clinical, biological, endoscopic, histological and radiolog-
ical data. Methods: The most important part of the diagnosis is
the histology, which is acquired by endoscopy. Imaging of the
small bowel has changed in recent years, but the imaging
goals are primarily to determine the extent of small bowel
involvement, assess complications and define candidates for
surgery. Imaging techniques are divided into conventional and
cross-sectional ones. Results: The spectrum of imaging find-
ings of cross-sectional techniques is discussed, emphasising
the advantages and limitations of each technique, acknowl-
edging the specificities of the paediatric population. Cross-
sectional techniques have advanced the ability to diagnose and
monitor inflammatory disease of the small bowel. Conclusion:
MR enterography is the technique of choice in children with
known IBD, for the investigation of the small bowel and the
whole GI tract. US should be the first choice examination in
children with suspected IBD, while CT should be reserved for
cases in which MRI is contraindicated or in acute emergency
situations when US is inadequate.
Teaching Points
• Cross-sectional imaging of the small bowel is essential in
paediatric IBD.
• Endoscopy is unable to assess extramural disease and
examine the entire small bowel.
• US should be the first choice examination in children with
suspected IBD.
• MR enterography is the technique of choice in children with
known IBD.
• There are still controversies regarding the prediction of
disease activity or fibrosis.
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Introduction
Inflammatory bowel disease (IBD) consists of a range of
diseases, which include Crohn's disease (CD), ulcerative co-
litis (UC) and IBD unclassified (IBDU). Approximately 1.6
million Europeans are affected with CD and 2.1 million with
UC, of whom 25 % of patients first present during childhood
or adolescence. Recent epidemiologic studies have document-
ed an increase in the incidence of paediatric IBD [1].
UC is characterised by continuous mucosal, colonic in-
flammation, while CD by skip lesions and transmural inflam-
mation, which may affect any part of the digestive tract. IBDU
(9% of paediatric IBD) refers to cases that cannot be classified
after complete clinical, radiological, endoscopic and patho-
logical evaluation, mainly because they present with features
of both diseases [2].
Environmental changes, genetic factors, intestinal microbi-
ota alterations and immune system deregulation contribute to
the initiation and progression of inflammation and conse-
quently fibrosis, the two main components of IBD [3].
Paediatric IBD (PIBD) is characterised by different atypical
phenotypes from the adult-onset disease because of a different
genetic basis and age-related regulation of the inflammatory
process [4]. Atypical presentation of UC includes rectal
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sparing in untreated patients, short duration of disease, upper
gastrointestinal (GI) tract involvement, caecal patch and acute
transmural disease [2]. Location and severity of CD lesions in
children are more extensive and aggressive in the left colon,
while terminal ileitis is the usual pattern of inflammation in
adults [4]. IBD phenotypes are reported related to the clinical
outcome, so accurate characterisation is of great importance.
The most recently validated Paris classification includes loca-
tion, severity, morphology (structuring, penetrating), patient’s
age and growth delay [5].
The diagnosis of PIBD is based on the integration of
clinical, biological, endoscopic, histological and radiological
data, and no single study is diagnostic. According to the
revised Porto criteria, the recommendations for diagnosis
include esophagogastroduodenoscopy and ileocolonoscopy
with random biopsies from all segments of the GI tract, while
adequate imaging studies of the small bowel (SB) are recom-
mended in all suspected cases of IBD, particularly patients
with suspected CD, atypical UC and IBDU [2]. While endos-
copy is the gold standard modality as it provides a definite
diagnosis, it has certain limitations: invasiveness, need for
sedation, inability to assess extramural disease and inadequate
visualisation of SB. Capsule endoscopy is a relatively new
technique, which can be applied in children for evaluation of
SB, with high specificity and sensitivity in CD, comparable to
MR enterography with the main drawback of low specificity
in the evaluation of the jejunum [6]. Its main disadvantages
consist of: inability to evaluate extramural pathology, contra-
indication of strictures, 15–27 % incomplete recording and
8 % retention risk. Recently, in order to avoid retention risk, a
new dissolving test capsule—named the patency capsule
(PC)—was introduced in clinical practice. Newer improved
versions of the PC further eliminate obstruction risk [7–9].
Paediatric IBD imaging studies
Multiple imaging modalities have been used in paediatric
IBD, divided into conventional and cross-sectional ones.
The small bowel follow-through (SBFT) had been the most
common examination of the SB, with a sensitivity and spec-
ificity of 90 and 96 % respectively for the diagnosis of CD
[10]. Its use as a gold standard technique for radiological
examination of the SB was justified before the introduction
of cross-sectional modalities because of its high negative
predictive value and ability to identify even subtle mucosal
abnormalities in experienced hands.
Themethodwith its high availability and low cost probably
could still play a role in the diagnosis of IBD lesions, espe-
cially in strictures with obstruction.
SΒ enteroclysis has limited use in children because of the
high radiation dose and the stress and discomfort it causes.
Both barium studies are unable to demonstrate
extraluminal disease, while they have the disadvantage of a
high radiation dose. Furthermore, in a number of studies,
cross-sectional techniques, especially MRI, have been shown
to be superior to SBFT for detecting small intestinal pathology
[11, 12].
Cross-sectional techniques have advanced the ability to
diagnose, classify and monitor IBD while reducing the radia-
tion exposure. When employed under the appropriate clinical
scenario, they play a crucial role: first to suggest or confirm
the diagnosis of IBD in suspected cases, excluding other
causes of inflammation, especially infection; second, to dif-
ferentiate between IBD subtypes and contribute to the accu-
rate classification of IBD; third, in known IBD, to evaluate
response to therapy and disease activity (inflammation or/and
fibrosis) and monitor progression and intestinal or extra-
intestinal complications of the disease, thus suggesting the
appropriate therapy. These techniques share the limitation of
relatively low sensitivity to early/mild disease, restricted to the
mucosa, when the predominant histological findings are
erythaema and friability without ulcers because of the current
limitations in spatial resolution [13].
Ultrasound (US)
Transabdominal ultrasound (TUS) and small intestine contrast
ultrasound (SICUS) are radiation-free, low-cost and easy to
use radiographic techniques with high availability and good
tolerance by children. They can be performed with little
preparation and without sedation. Fasting 4 h before the
examination is helpful. The use of oral and/or IV contrast
agents remains controversial, but has been shown to be a safe
and well-tolerated practice that increases diagnostic accuracy
[14]. In patients with suspected CD, the sensitivity and spec-
ificity of both methods in detecting small bowel lesions are
shown to be 75 and 100 % for TUS and 100 and 100 % for
SICUS, while in patients with proven CD the sensitivity and
specificity can reach 76 and 100 % for TUS and 96 and 100 %
for SICUS respectively [15]. Another advantage of US is the
real-time evaluation of bowel wall for both anatomic and
functional abnormalities. Sensitivity is reported to be signifi-
cantly lower for less accessible locations such as rectum
(14.2 %) and duodenum/jejunum (28.6 %) [16].
In general, the US protocol requires greyscale and col-
our Doppler imaging of the entire abdomen in the sagittal
and axial planes using anterior and posterior compression
techniques, at first with a high-resolution probe beginning
with the terminal ileum, then examining the colon from the
left to right, and finally evaluating the jejunal and ileal
loops in the left upper and mid-lower abdomen respective-
ly. Urinary bladder distension from previous oral intake
enables better visualisation of intrapelvic ileal loops, while
74 Insights Imaging (2015) 6:73–83
Insights Imaging (2015) 6:73–83 75
Fig. 1 Sagittal greyscale US (a) in a 13-year-old female: ileocolic
Crohn’s disease. Bowel wall thickening with modification of normal
stratification. Sagittal colour Doppler (b), axial power Doppler (c) plane:
active Crohn’s disease. Increased vascularity in the thickened bowel wall
segments. Sagittal colour Doppler image (d) of the left colon in a 15-year-
old male with UC shows thickened and moderately hyperaemic bowel
wall segment with preservation of normal stratification
drinking water immediately before scanning enables iden-
tification of gastric and duodenal abnormalities. Finally,
using a low-frequency probe, the mesentery is inspected
for fluid or abscesses and solid organs for related abnor-
malities [17]. Ultrasound findings to look for are the fol-
lowing [15–20]:
& Bowel wall thickening (>3 mm) (Fig. 1a). It is one of the
most important findings in IBD. Different cutoff measure-
ments of the bowel wall have been proposed in the liter-
ature (for the terminal ileum: 1.5–3 mm; for the colon: 2–
3 mm), with higher thresholds resulting in lower sensitiv-
ity and increased specificity [18]. In our department the
cutoff measurement used for the SB and the colon is
3 mm.
& Modification (thickened submucosa) or loss of normal
stratification.
& Bowel stiffness: non-compressible and hypoperistaltic
bowel loops.
& Strictures (lumen diameter <1 cm) with prestenotic dis-
tention (lumen diameter >2.5 cm). Hyperperistalsis of the
prestenotic loop is an additional finding.
& Ulcers: interruption of the submucosal hyperechoic rim by
a hypoechoic tract, hyperechoic tracts perpendicular to the
bowel wall or hyperechoic spots (trapped gas) in the
bowel wall. Loss of stratification is also thought to be an
indirect sign of chronic disease due to the development of
ulcers.
& Fistulas: hypoechoic, duct-like peri-intestinal lesions with
lumen diameter <2 cm.
& Abscesses: thick walled, hypoechoic, peri-intestinal
round-like lesions.
& Inflammatory mesentery: appears thickened, echogenic
and hyperaemic. Free fluid accumulation. Enlarged hyper-
emic mesenteric nodes.
Colour or power Doppler imaging of the vascularity of
thickened wall segments has been proved useful in the dis-
tinction between remission and active disease, as normal
bowel wall does not show much vascularity (Fig. 1b and c).
The estimation of “vessel density” seems to be a reliable
semiquantitative score for disease activity [21]. Additionally,
patients with CD have significantly higher portal vein and
Fig. 1 (continued)
76 Insights Imaging (2015) 6:73–83
mesenteric flow and a lower resistance index (RI) than con-
trols, although these measurements have not been properly
validated and are not clinically applicable [18].
Contrast-enhanced ultrasound (CEUS) is a newer diagnos-
tic tool in paediatric IBD. Its use in the paediatric population
has been reported safe [14], while in adult studies it has been
shown to increase the diagnostic accuracy of detecting CD
lesions and additionally to differentiate active from chronic
lesions [22]. This is probably due to the unique characteristic
of US contrast agents to remain inside the microcirculation
and break up in the vascular system, so they are not retained in
tissues that do not have an increased micro- or macrovascular
network, such as the fibrous intestinal wall. More studies are
needed to justify the reliability and feasibility of this promis-
ing technique in the paediatric population.
Ultrasound elasticity, although far from clinical employ-
ment in bowel wall assessment, represents a promising real-
time objective diagnostic tool in the detection and measure-
ment of fibrosis in IBD. So far, it has been shown that it can
accurately differentiate inflammatory from fibrotic bowel in
rat models of IBD [23].
The clinical role of US in UC is less well established
compared with CD. Mural stratification is preserved in most
UC patients because of the mucosal/submucosal pattern of
inflammation. Bowel wall thickening is also a characteristic
feature (Fig. 1d). Pathologic RI measurements in the inferior
mesenteric artery related to disease activity have been re-
ported [19].
Amongst the disadvantages of US are the facts that the
examination is operator dependent and not reproducible and
that it is difficult to examine the whole GI tract, with addi-
tional difficulties in obese children and in case of gas full-
ness of the bowel.
Key points
Being radiation free, low cost and easy to use and having
high availability, good tolerance, and high sensitivity and
specificity for terminal ileum lesions [20] make ultrasound a
first-line imaging technique for IBD especially for (1)
screening, (2) suspected IBD, particularly when MRE is
not possible because of young age or need for sedation,
and (3) evaluation of post-treatment changes, particularly
in cases of isolated terminal ileum disease.
Computed tomography (CT)
CT examination by either CT enterography (CTE) or CT
enteroclysis has become a widely used technique in adults
for SB investigation. The latter is rarely performed especial-
ly in children because it is more invasive and probably of
similar diagnostic accuracy, as shown in an adult study [24].
CTE has become the preferred imaging technique for eval-
uating IBD because of certain advantages over MRI: shorter
examination time, convenient procedure, greater availability,
increased radiologist familiarity and experience in interpreting
findings, high spatial resolution, fewer motion artefacts, less
need for sedation, lower cost and availability for patients with
implanted MR-sensitive devices [25].
Despite the well-established benefits of CTE, there is in-
creasing concern about the radiation risk and consequent
malignancy risk, especially in this already predisposed paedi-
atric population. Therefore, mainly for radiation protection
reasons, MDCT is avoided by most paediatric radiologists.
However, iterative reconstruction algorithms in CTE have
shown that a decrease of effective doses to less than 2 mSv
is possible with considerably lower image quality but without
missing clinically significant diagnostic information [26, 27].
The feasibility and integration into daily clinical practice of
these low-dose techniques require further investigation and
standardisation.
CT findings to look for include [13, 21, 24, 28]:
Fig. 2 Crohn’s disease: coronal CTE. Terminal ileum involvement in a
14-year-old male: bowel wall thickening, submucosal oedema, lumen
stenosis and increased mucosal enhancement
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& Bowel wall thickening greater than 3 mm in a distended
bowel loop.
& Mural hyperenhancement (Fig. 2) and segmental
hyperenhancement of the small bowel wall compared
with the adjacent small bowel loops. Using a mural
attenuation threshold of 109 HU and an abnormal to
normal loop enhancement ratio of more than 1.3, CTE
is highly correlated with histological findings of active
disease. Visual assessment, however, presents higher
specificity than quantitative measurements do [21].
& Mural stratification due to intramural oedema is more
indicative of active disease compared to a homogeneously
enhanced wall, while the presence of submucosal fat
indicates a more chronic process.
& The “comb sign”. Increased attenuation of the mesenteric
fat is due to oedema and engorgement of the vasa recta.
& Chronic fibrostenosing disease. Strictures without mural
hyperenhancement or other signs of active inflammation.
& Sacculations. The inflammatory process of CD usually
affects the mesenteric border of the bowel loops, so when
fibrosis is established, stricturing and shortening of the
mesenteric side result in compensatory dilatation of the
anti-mesenteric wall.
& Fibrofatty proliferation.
& Sinus tracts or fistulas. Fistulas with oedematous origins
that are not visible on SBFT may be detected at CT as
linear enhancing tracts with or without communication
with adjacent structures, tethering bowel loops. The most
common type of fistula in CD is a perianal fistula. Other
fistula types include enterocutaneous, rectovaginal,
enterovaginal and enterovesicular. Lifetime risk of fistu-
lous disease in CD is 20–40 % [29].
Fig. 3 Extraintestinal
manifestations of Crohn’s disease
in a 14-year-old male. Sacroilitis
in Crohn’s disease. Increased
contrast enhancement (a, b, c) and
restricted diffusion (d) in the
sacroiliac joints. Focal irregular
stenosis in the common bile duct
(thin arrow) and hepatic bile duct
confluence (thick arrow). Pre-
stenotic dilatation of the left
hepatic duct (arrowhead). The
imaging findings are typical of
primary sclerosing cholangitis in
CD (e)
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& Abscesses are easily depicted on CTE.
& Treatment response. Mural hyperenhancement and bowel
wall thickening, the most sensitive signs of active disease,
are significantly decreased after therapy. The pattern of
mural stratification usually changes from stratification
with mucosal hyperenhancement toward homogeneous
enhancement.
& CT has low sensitivity for detection of ulcers. Deep mural
ulcers may present as focal bowel wall defects that contain
fluid or oral contrast material. Adjacent bowel wall
hyperenhancement is usually seen.
& Inflammatory pseudopolyps can be seen in distended
bowel.
& Pneumatosis, unsuspected perforation and mural thinning
in patients with toxic megacolon.
& Extraenteric manifestations of CD can also be evaluated
with CT or MR imaging (Fig. 3): sclerosing cholangitis,
cholelithiasis, liver abscess, portal vein thrombosis, pan-
creatitis, hydronephrosis caused by ureteral involvement,
nephrolithiasis, IBD-related arthropathy (progressive an-
kylosing spondylitis and sacroiliitis), osteoporosis, perito-
neal pseudocysts and cutaneous manifestations [30].
Key points
CTE, due to its radiation risk, is mainly preferred for acute
emergency situations, assessing potential complications of
IBD that require surgical management, such as perforation,
peritonitis, post-operative leaks, abscess, severe strictures/
obstruction and fistulas. It remains an examination of choice
for abscess drainage, used in order to obtain more accurate
images of the exact extension and select the most appropriate
access route.
Magnetic resonance imaging (MRI)
MR enterography (MRE) of the small bowel is a recent
technique that is currently widely applied in the adult popula-
tion and to a significant degree in children. It is performed
either as MR enterography or MR enteroclysis. In children,
because of its simplicity and the lack of radiation exposure (no
need to advance a catheter in the jejunum under fluoroscopic
guidance), MR enterography is the preferred technique.
However, problems such as imaging artefacts due to bowel
peristalsis and motion or poor cooperation of the child with
the oral contrast agent can cause an examination to be of poor
quality. For these reasons the technique is preferably applied
in patients above the age of 9, while there is no need for
sedation [31]. According to a recent meta-analysis in the
paediatric population, the sensitivity and specificity of MR
enterography in active CD has been reported to be 84 and
97 % respectively [32, 33].
There are still controversies concerning the prediction of
disease activity because of the lack of a gold standard exam-
ination for comparison, the different MR techniques used and
Fig. 4 Coronal T2 steady-state acquisition image in a 14-year-old male. Bowel wall thickening, strictures, ulceration, pseudopolyps and
pseudosacculation
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the fact that acute and chronic lesions may coexist in the same
bowel loop (Fig. 4). However, MRI has been shown to be the
best imaging technique to differentiate active inflammation
from fibrosis. For active disease, the sensitivity and specificity
of MRE are estimated as 87.5 and 79.3 % compared to 100
and 62.1 % for CTE, while for fibrosis, the sensitivity and
specificity of MRE are 57.1 and 82.1 % compared to 42.3 and
67.9 % of CTE respectively [28].
Specific MR findings suggestive of acute active inflamma-
tory stage in CD include [28, 29] (Figs. 5 and 6):
& Bowel wall thickening (greater than 3 mm) with increased
signal in the abnormal bowel wall and adjacent mesentery
on T2W fat-suppressed images.
& Early intense mucosal enhancement followed by
progressive transmural enhancement on post-
gadolinium T1W images. Layered wall morphology
has been attributed to exacerbation of mucosal in-
flammation in chronic disease, while homogeneous
enhancement is more common in newly diagnosed
CD [34].
& Ulcers and fistulas are best seen on fast imaging with
steady-state precession. They show avid contrast enhance-
ment (Fig. 5).
& Reactively enlarged (>5 mm in short axis) adjacent mes-
enteric nodes often exhibit contrast enhancement and high
signal on diffusion-weighted image (DWI).
& DWI sequences with high b-values open new horizons in
the detection and quantification of bowel wall
inflammation. In the adult population, detection of IBD
with DWI sequences has a sensitivity of 95 % and speci-
ficity of 82 %, which is the highest sensitivity but lowest
specificity ever reported compared with previous tech-
niques. Neubauer et al. showed that DWI in combination
with T2W is at least equal to CE-MRI for detecting acute
lesions in CD (Fig 6). Based on these two sequences,
imaging without the need of contrast media seems to be
sufficient for diagnosis, reducing the scanning time to less
than 10 min [34]. Promising attempts have been made to
measure CD activity quantificatively using DWI and CE-
MRI.
Chronic disease without active inflammation (Fig. 7).
& Bowel wall thickening and homogeneous slow enhance-
ment on delayed post gadolinium T1W images with low
signal intensity on T2W FS images. Strictures and ob-
struction are usually evident.
& New sequences have been applied to specifically detect
fibrosis. The magnetisation transfer (MT) technique re-
flects data of a different set of molecular properties than
standard T1 and T2 imaging. MT MRI is a quantificative
measurement of the energy transferred from protons in
free mobile water molecules compared to protons in water
molecules associated with large molecules such as pro-
teins and collagen. Therefore, fibrotic tissue exhibits a
highMTeffect, which—as shown byAdler et al. in animal
studies—correlates with the degree of fibrosis and the
Fig. 5 Ileocutaneous fistula in a 13-year-old male. T2 fat-saturated (1a–c) and T1 contrast-enhanced (2a–c) images. Direct visualisation of the fistula
(arrows) is feasible as it shows avid contrast enhancement and contents of increased T2 signal, suggestive of enteric material
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Fig. 7 Disease chronicity in a 16-year-old male. Low signal intensity of
the bowel wall in the axial T2-steady state acquisition image (a) and fat-
saturated T2 image (b) without restricted diffusion (c). Delayed
progressive homogeneous enhancement on coronal delayed arterial (d),
coronal (e) and axial (f) equilibrum phase images
Fig. 6 Crohn’s disease: terminal ileum involvement in a 14-year-old
female. Disease activity. Increased signal of the bowel wall in coronal
T2 steady-state acquisition (a) with restricted diffusion (d). Prominent
early mucosal enhancement on post-gadolinium T1W images in 30 s (c)
and more homogeneous enhancement in 120 s (b)
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amount of type I collagen. Pazahr et al. showed that MT
can be measured in the human bowel wall with promising
results using a 2D encoded gradient-echo sequence with a
MT prepulse. The short acquisition time makes it attrac-
tive for everyday clinical practice [35, 36].
Motility imaging is a new MRI technique, quantificating a
functional parameter, with high correlation to histopathology
and shown to be more accurate than conventional MRI in the
detection and severity grading of lesions in both active and
chronic CD. Although more studies are required to establish
the feasibility of this technique in clinical practice and for
classification of motility disorders, it seems a promising tool
for assessing the severity of disease [37].
Extraintestinal manifestations of IBD are easily detectable
with MRI; sclerosing cholangitis, one of the most serious
ones, with a relatively high prevalence in IBD patients
(~4.5 %), has been shown to be easily and accurately inves-
tigated with MR cholangiopancreatography (MRCP). MRCP
is a non-interventional method that also has the benefit of no
need for sedation or exposure to radiation and comparable
results to the gold standard technique, ERCP [30, 38].
Key points
MRI is a radiation free technique with diagnostic accuracy at
least comparable to that of CT. Although limited clinical data
exist, it has been shown that MRI is the most sensitive tech-
nique to differentiate fibrosis from active inflammation. Recent
technical advances in body MRI, including the 3-T magnetic
field, parallel image processing and motion artefact reduction
techniques, raise hopes for shorter scan times and increased
spatial resolution for detecting early inflammatory changes [28,
39].
Conclusion
US should be the first choice examination in children with
suspected IBD and should be performed before endoscopy,
while MR enterography is the technique of choice in children
with known IBD for the investigation of the small bowel and
the whole GI tract, as it is a reproducible and well-tolerated
examination, lacking radiation and providing excellent infor-
mation about bowel disease. CT should be reserved for cases
where MRI is contraindicated, for non-cooperative younger
children or in acute-emergency situations when US is inade-
quate. SBFTcurrently has a questionable role as it seems to be
widely replaced by MR enterography in the paediatric popu-
lation, despite its lower cost. It should be used for very young
children where performing either MR or CT enterography is
impossible.
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